34 Followers on Owler

Pearl Therapeutics

focuses on developing products for the treatment of prevalent respiratory diseases and chronic obstructive pulmonary diseases... Read more
OverviewCompetitorsFundingNews & Insights

Pearl Therapeutics

focuses on developing products for the treatment of prevalent respiratory diseases and chronic obstructive pulmonary diseases... Read more
Pearl Therapeutics CEO: undefined undefined

CEO

Add

CEO Approval Rating

- -/100

2006

PrivateAcquired by AstraZeneca UK Limited

Pharmaceuticals & Biotechnology
Pharmaceuticals
2834 NAICS listing

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
100-250
Agree?
Funding
$175M

News

Mar 13, 2018
Contract Pharma
Pearl Therapeutics: Avillion, Pearl Therapeutics Sign Clinical Agreement
Mar 18, 2015
FIERCE BIOTECH
Pearl: AstraZeneca's $1.2B COPD drug comes through in Phase III
Sep 23, 2014
TRIANGLE BUSINESS JOURNAL
Pearl: AstraZenaca's Pearl Therapeutics expands Durham laboratory - again

Pearl Therapeutics Competitors

1Pulmatrix
2Verona Pharma
3Spyryx Biosciences
4Enterprise Therapeutics
5ReViral
6Savara
7Synairgen
8Vectura
9Aerogen
10OxyMaster
Unlock 19 + competitors

Trending Companies